STAT3 and head and neck squamous cell carcinoma: STAT3 is also a major therapeutic target under investigation for HNSCC/OSCC/GC [reviewed (71, 72, 82)] and while studies are predominantly at the preclinical or early clinical stage, they hold some promise.